Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
- 19 May 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 396 (2-3) , 85-92
- https://doi.org/10.1016/s0014-2999(00)00226-0
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the ratBritish Journal of Pharmacology, 1999
- Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptorEuropean Journal of Pharmacology, 1999
- Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological FunctionBiochemical and Biophysical Research Communications, 1999
- The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferationProceedings of the National Academy of Sciences, 1998
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- Cannabinoid receptor agonists and antagonistsExpert Opinion on Therapeutic Patents, 1998
- Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cellsBiochemical Journal, 1997
- Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in LeukocytesJournal of Biological Chemistry, 1997
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Nerve growth factor in the synovial fluid of patients with chronic arthritisArthritis & Rheumatism, 1992